Method and apparatus for discriminating tachycardia events in a medical device

• US 9,526,908 B2
• Filed: 04/01/2014
• Issued: 12/27/2016
• Est. Priority Date: 04/01/2014
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Zhang, Xusheng, Stadler, Robert W
• Primary Examiner(s): D ABREU, MICHAEL JOSEPH
• Application Number:
  US14/242,536
• Publication Number:
  US 20150273229A1
• Time in Patent Office: 1,001 Days
• US Class Current: 1/1
• CPC Class Codes: A61B 5/35 by template matching
• CPC Class Codes: A61B 5/361 Detecting fibrillation
• CPC Class Codes: A61B 5/363 Detecting tachycardia or bradycardia
• CPC Class Codes: A61N 1/3925 Monitoring; Protecting

Abstract

A method and medical device for detecting a cardiac event that includes sensing cardiac signals from a plurality of electrodes, the plurality of electrodes forming a first sensing vector and a second sensing vector, determining, in response to the cardiac event being identified as a shockable event, a first R-wave morphology corresponding to R-waves of a next interval subsequently sensed along the first sensing vector during the predetermined sensing window and a second R-wave morphology corresponding to R-waves of a next interval subsequently sensed along the second sensing vector, determining whether the next interval subsequently sensed along the first sensing vector and the next interval subsequently sensed along the second sensing vector satisfy a morphology metric, and identifying the cardiac event as one of a monomorphic ventricular tachycardia and a polymorphic ventricular tachycardia in response to the determined first R-wave morphology, second R-wave morphology, and the next interval subsequently sensed along the first sensing vector and the next interval subsequently sensed along the second sensing vector not satisfying the morphology metric.

Claims

1. A medical device for delivering therapy in response to a cardiac event, comprising:

a housing;

sensing circuitry positioned within the housing and configured to obtain a cardiac signal sensed via a plurality of electrodes electrically coupled to the sensing circuitry, the plurality of electrodes forming a first sensing vector and a second sensing vector; and

a processor positioned within the housing and configured to analyze the sensed cardiac signal to identify the cardiac event as one of a shockable event or a non-shockable event based on a first segment of the cardiac signal sensed along the first sensing vector during a first predetermined sensing window and a second segment of the cardiac signal simultaneously sensed along the second sensing vector during the predetermined sensing window, determine, in response to the cardiac event being identified as a shockable event, a first R-wave morphology corresponding to R-waves of a third segment of the cardiac signal subsequently sensed along the first sensing vector during a second predetermined sensing window and a second R-wave morphology corresponding to R-waves of a fourth segment of the cardiac signal subsequently sensed along the second sensing vector during the second predetermined sensing window, determine whether the third segment of the cardiac signal and fourth segment of the cardiac signal are within a ventricular tachycardia shock zone, and identify the cardiac event as one of a monomorphic ventricular tachycardia or a polymorphic ventricular tachycardia based on the determined first R-wave morphology, second R-wave morphology, and the third and fourth segments of the cardiac signal being within the ventricular tachycardia shock zone.

2. The medical device of claim 1, wherein the processor is further configured to compare the R-waves of the third segment of the cardiac signal and the R-waves of the fourth segment of the cardiac signal to an R-wave template, determine whether a ventricular tachycardia morphology match is satisfied based on the comparing, and identify the cardiac event as polymorphic ventricular tachycardia in response to the ventricular tachycardia morphology match not being satisfied.

3. The medical device of claim 2, wherein the processor is further configured to determine R-wave widths of the R-waves of the third segment of the cardiac signal and the R-waves of the fourth segment of the cardiac signal, determine whether an R-wave width threshold is satisfied for both the first sensing vector and the second sensing vector in response to the determined R-wave widths, and identify the cardiac event as a non-shockable event in response to both the ventricular tachycardia morphology match being satisfied and the R-wave width threshold being satisfied for both the first sensing vector and the second sensing vector.

4. The medical device of claim 2, wherein the processor is further configured to determine R-wave widths of the R-waves of the third segment of the cardiac signal and the R-waves of the fourth segment of the cardiac signal, determine whether an R-wave width threshold is satisfied for both the first sensing vector and the second sensing vector in response to the determined R-wave widths, and identify the cardiac event as a non-shockable event in response to the ventricular tachycardia morphology match being satisfied, the R-wave width threshold not being satisfied for both the first sensing vector and the second sensing vector, and the third segment of the cardiac signal and the fourth segment of the cardiac signal not being within the ventricular tachycardia shock zone.

5. The medical device of claim 2, wherein the processor is further configured to determine R-wave widths of the R-waves of the third segment of the cardiac signal and the R-waves of the fourth segment of the cardiac signal, determine whether an R-wave width threshold is satisfied for both the first sensing vector and the second sensing vector in response to the determined R-wave widths, and identify the cardiac event as monomorphic ventricular tachycardia in response to the ventricular tachycardia morphology match being satisfied, the R-wave width threshold not being satisfied for both the first sensing vector and the second sensing vector, and the third segment of the cardiac signal and the fourth segment of the cardiac signal being within the ventricular tachycardia shock zone.

6. The medical device of claim 1, wherein determining whether the third segment of the cardiac signal and the fourth segment of the cardiac signal are within a ventricular tachycardia shock zone comprises:

determining a first low slope content of the third segment of the cardiac signal and a second low slope content of the fourth segment of the cardiac signal;

determining a first normalized mean rectified amplitude of the third segment of the cardiac signal and a second normalized mean rectified amplitude of the fourth segment of the cardiac signal; and

determining whether the third segment of the cardiac signal and the fourth segment of the cardiac signal are within a ventricular tachycardia shock zone in response to the determined first low slope content, second low slope content, first normalized mean rectified amplitude, and second normalized mean rectified amplitude.

7. The medical device of claim 1, wherein the processor is further configured to delay the determination of the identifying the cardiac as a shockable event in response the cardiac event being identified as monomorphic ventricular tachycardia.

8. The medical device of claim 7, wherein the processor is further configured compare, during delay of identifying the cardiac event being shockable, a first selected R-wave of the R-waves associated with the third segment of the cardiac signal with R-waves associated with the third segment of the cardiac signal other than the first selected R-wave, compare a second selected R-wave of the R-waves associated with the fourth segment of the cardiac signal with R-waves associated with the fourth segment of the cardiac signal other than the second selected R-wave, and determine whether the third interval and the fourth interval correspond to monomorphic ventricular tachycardia in response to the comparing.

9. The medical device of claim 8, wherein the processor is further configured to confirm the cardiac event being identified as a shockable event in response to both the third segment of the cardiac signal and the fourth segment of the cardiac signal being determined to correspond to monomorphic ventricular tachycardia.

10. The medical device of claim 9, wherein the processor is further configured to determine, in response to one or both of the third segment of the cardiac signal and the fourth segment of the cardiac signal not being determined to correspond to monomorphic ventricular tachycardia, whether the cardiac event has terminated, and determine whether to deliver therapy in response to the determining whether the cardiac event has terminated.